Luther King Capital Management (LKCM)’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,248
| Closed | -$206K | – | 629 |
|
|
2021
Q2 | $206K | Buy |
+1,248
| New | +$208K | ﹤0.01% | 600 |
|
|
2021
Q1 | – | Sell |
-20,521
| Closed | -$2.57M | – | 575 |
|
|
2020
Q4 | $2.57M | Buy |
20,521
+3,031
| +17% | +$339K | 0.01% | 255 |
|
|
2020
Q3 | $1.77M | Buy |
17,490
+2,626
| +18% | +$268K | 0.01% | 273 |
|
|
2020
Q2 | $1.45M | Sell |
14,864
-5,214
| -26% | -$485K | 0.01% | 276 |
|
|
2020
Q1 | $1.67M | Sell |
20,078
-1,906
| -9% | -$186K | 0.01% | 236 |
|
|
2019
Q4 | $2.44M | Buy |
21,984
+975
| +5% | +$100K | 0.02% | 266 |
|
|
2019
Q3 | $2.08M | Buy |
21,009
+1,276
| +6% | +$127K | 0.02% | 267 |
|
|
2019
Q2 | $1.96M | Sell |
19,733
-65
| -0.3% | -$6.2K | 0.01% | 272 |
|
|
2019
Q1 | $2.18M | Sell |
19,798
-2,412
| -11% | -$252K | 0.02% | 256 |
|
|
2018
Q4 | $2.04M | Sell |
22,210
-13,182
| -37% | -$1.33M | 0.02% | 253 |
|
|
2018
Q3 | $3.9M | Buy |
35,392
+285
| +0.8% | +$29.7K | 0.03% | 210 |
|
|
2018
Q2 | $3.28M | Sell |
35,107
-10,842
| -24% | -$934K | 0.03% | 228 |
|
|
2018
Q1 | $3.81M | Sell |
45,949
-66,933
| -59% | -$5.95M | 0.03% | 205 |
|
|
2017
Q4 | $10.3M | Sell |
112,882
-9,615
| -8% | -$800K | 0.08% | 145 |
|
|
2017
Q3 | $9.33M | Buy |
122,497
+6,730
| +6% | +$509K | 0.08% | 144 |
|
|
2017
Q2 | $8.68M | Sell |
115,767
-30,735
| -21% | -$2.13M | 0.08% | 152 |
|
|
2017
Q1 | $9.56M | Sell |
146,502
-64,860
| -31% | -$3.82M | 0.09% | 144 |
|
|
2016
Q4 | $11.7M | Sell |
211,362
-59,590
| -22% | -$3.27M | 0.11% | 137 |
|
|
2016
Q3 | $15.3M | Sell |
270,952
-64,580
| -19% | -$3.17M | 0.15% | 120 |
|
|
2016
Q2 | $14M | Buy |
335,532
+19,825
| +6% | +$913K | 0.14% | 142 |
|
|
2016
Q1 | $13.5M | Buy |
315,707
+91,285
| +41% | +$3.86M | 0.13% | 148 |
|
|
2015
Q4 | $10.2M | Sell |
224,422
-2,235
| -1% | -$93.9K | 0.1% | 191 |
|
|
2015
Q3 | $8.8M | Sell |
226,657
-3,608
| -2% | -$144K | 0.09% | 202 |
|
|
2015
Q2 | $8.37M | Buy |
+230,265
| New | +$7.28M | 0.07% | 225 |
|
Other funds holding PRAH
Luther King Capital Management (LKCM)'s PRAH Position: Q3 2021 in Review
Luther King Capital Management (LKCM) sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 1,248 shares — an estimated $206K sold.
Luther King Capital Management (LKCM) first reported a position in PRAH in Q2 2015 and held it in 24 quarters. The position peaked at $15.3M in Q3 2016. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Luther King Capital Management (LKCM) reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Luther King Capital Management (LKCM) sold 1,248 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $206K.
- Luther King Capital Management (LKCM) first reported a position in PRA Health Sciences, Inc. in Q2 2015 and held it in 24 quarters.
- Luther King Capital Management (LKCM)'s PRA Health Sciences, Inc. position peaked at $15.3M in Q3 2016.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Luther King Capital Management (LKCM)'s 13F filing for Q3 2021, filed 10 Nov 2021.